Ultra-fast hit identification in ultra-large chemical spaces for any human disease protein through AI. Our proprietary platform predicts drug-protein interactions with unprecedented speed and accuracy, unlocking previously “undruggable” disease targets and dramatically reducing R&D costs. By leveraging vast biological data and scalable AI, we empower biotech and pharma companies to accelerate drug development, identify novel candidates, and navigate complex chemical spaces with minimal IP constraints. We are making AI-powered drug discovery accessible, efficient, and transformative. Want to learn more? Reach out at contact@factorize.bio or visit www.factorize.bio #AI #Biotech #DrugDiscovery #Innovation
| Website | https://www.factorize.bio/ |
| Employees | 1 (1 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular factorize.bio employee's phone or email?
Jörn Schmiedel is the Co-Founder and CEO of factorize.bio.
1 people are employed at factorize.bio.
factorize.bio is based in Berlin, Berlin.